These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1811361)

  • 1. Disseminated intravascular coagulopathy associated with rifampicin.
    Ip M; Cheng KP; Cheung WC
    Tubercle; 1991 Dec; 72(4):291-3. PubMed ID: 1811361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment.
    Costiniuk CT; McCarthy AE; Talreja H; Zimmerman D; Liu TT; Owen E; Angel JB
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):421. PubMed ID: 21333117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
    Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
    Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin-induced disseminated intravascular coagulation in pulmonary tuberculosis treatment: A case report and literature review.
    Chen G; He JQ
    Medicine (Baltimore); 2017 Feb; 96(7):e6135. PubMed ID: 28207542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated intravascular coagulopathy as an adverse reaction to intermittent rifampin schedule in the treatment of leprosy.
    Souza CS; Alberto FL; Foss NT
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):366-71. PubMed ID: 9401490
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.
    Havey TC; Cserti-Gazdewich C; Sholzberg M; Keystone JS; Gold WL
    Am J Trop Med Hyg; 2012 Feb; 86(2):264-7. PubMed ID: 22302861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic complexity of rifampicin-induced coagulopathy in a patient with spontaneous muscle bleeding: A case report.
    Vučić D; Cvitkušić-Lukenda K; Dunđer I; Gabaldo K; Knežević-Praveček M; Miškić B
    Medicine (Baltimore); 2021 Jul; 100(26):e26234. PubMed ID: 34190146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute renal failure due to rifampicin.
    Agnihotri MS; Bansal S; Kumar A
    Indian J Chest Dis Allied Sci; 1990; 32(2):125-8. PubMed ID: 2083961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis.
    Murray AN; Cassidy MJ; Templecamp C
    Nephron; 1987; 46(4):373-6. PubMed ID: 3658067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin-induced disseminated intravascular coagulation: An antibody-mediated side effect.
    Sousa G; Carreiro A; Duarte P
    Pulmonology; 2021; 27(3):269-272. PubMed ID: 32439299
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 17. Disseminated intravascular coagulation (DIC) during superacute haemolysis in a patient with ovarian dermatoid cyst treated with rifampicin.
    Nowicka J; Kotschy M; Chwistecki K; Jeleń M
    Haematologia (Budap); 1977; 11(3-4):359-64. PubMed ID: 617955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased insulin requirement in a patient with type 1 diabetes on rifampicin.
    Atkin SL; Masson EA; Bodmer CW; Walker BA; White MC
    Diabet Med; 1993 May; 10(4):392. PubMed ID: 8508626
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated intravascular coagulation associated with pulmonary tuberculosis.
    Fujita M; Kunitake R; Nagano Y; Maeda F
    Intern Med; 1997 Mar; 36(3):218-20. PubMed ID: 9144018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.